靶控输注舒芬太尼复合依托咪酯对高龄患者气管插管反应的影响  被引量:7

Effects of target controlled infusion of sufentanil combined with etomidate on elderly patients with tracheal intubation response

在线阅读下载全文

作  者:姚琳[1] 赵泽宇[2] 

机构地区:[1]陕西省商洛市中心医院麻醉科,商洛726000 [2]四川省广元市中心医院麻醉科

出  处:《陕西医学杂志》2015年第4期447-449,共3页Shaanxi Medical Journal

基  金:四川省卫生厅课题基金(080139)

摘  要:目的:观察靶控输注不同剂量舒芬太尼复合依托咪酯对高龄患者气管插管反应的影响。方法:选择本院于2013年9月至2014年9月收治的需行全身麻醉高龄患者100例作为研究对象,随机分为两组,观察组靶控输注0.35μg/L舒芬太尼及依托咪酯0.5mg/L行麻醉诱导,对照组靶控输注0.40μg/L舒芬太尼及依托咪酯0.5mg/L,比较两组患者诱导时血流动力学变化及不良反应发生率。结果:观察组插管前即刻、插管后即刻及插管后1min、3min、5min心率及平均动脉压均更为平稳(P<0.05)。术后经随访两组未见不良反应(P>0.05)。结论:靶控输注0.35μg/L舒芬太尼及依托咪酯0.5mg/L对高龄患者气管插管反应影响小,患者血流动力学更为稳定。Objective:To observe the effects of target controlled infusion of different doses of sufentanil combined etomidate on elderly patients with tracheal intubation response.Method :100cases of elderly patients needed general anesthesia and treated in the hospital in 2014 March-2014 September were selected as the research objects,they were divided into two groups.The observation group adopted target controlled infusion of 0.35μg/L sufentanil and 0.50μg/L etomidate for induction of anesthesia,the control group took target controlled infusion of 0.40μg/L sufentanil and 0.50μg/L etomidate,to compare hemodynamic changes and incidence of adverse reaction between two groups.Result:According to the result of analysis,the observation group intubation immediately before and after intubation and 1min,3min,5min after intubation,heart rate and mean arterial pressure were more stable(P〈0.05),The two groups had no adverse reaction followed up after operation(P〉0.05).Conclusion:The effect of tracheal intubation response with target controlled infusion of 0.35ug/L sufentanil and 0.5mg/L of etomidate on senile patients is smaller,and heart rate and mean arterial pressure is more stable.

关 键 词:插管法 气管内 舒芬太尼 依托咪酯 老年人 

分 类 号:R614[医药卫生—麻醉学]

 

参考文献:

正在载入数据...

 

二级参考文献:

正在载入数据...

 

耦合文献:

正在载入数据...

 

引证文献:

正在载入数据...

 

二级引证文献:

正在载入数据...

 

同被引文献:

正在载入数据...

 

相关期刊文献:

正在载入数据...

相关的主题
相关的作者对象
相关的机构对象